# Pathfinder Cell Therapy, Inc. (PFND)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/PFND/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2015 | $ 0 | $ -1.43M | $ -634.6K | $ 5.41M | $ -6.73M |
| 2014 | $ 0 | $ -2.18M | $ -1.36M | $ 4.98M | $ -5.94M |
| 2013 | $ 76.8K | $ -2.42M | $ -2.28M | $ 3.99M | $ -4.55M |
| 2012 | $ 164.6K | $ -3.11M | $ -2.92M | $ 1.55M | $ -2.85M |
| 2011 | $ 324.7K | $ -15.01M | $ -3.42M | $ 318.0K | $ -707.0K |
| 2010 | $ 520.9K | $ -3.14M | $ -1.95M | $ 462.0K | $ -973.0K |
| 2009 | $ 545.1K | $ -6.21M | $ -5.52M | $ 7.0K | $ 842.0K |
| 2008 | $ 274.1K | $ -6.67M | $ -5.89M | $ 8.0K | $ 2.90M |
| 2007 | $ 204.4K | $ -7.00M | $ -5.46M | $ 0 | $ 2.82M |
| 2006 | $ 215.0K | $ -5.90M | $ -4.15M | $ 70.0K | $ 3.33M |
| 2005 | $ 0 | $ -3.25M | $ -2.91M | $ 40.0K | $ 134.0K |
| 2004 | $ 22.7K | $ -2.79M | $ -2.36M | $ 110.0K | $ 1.48M |
| 2003 | $ 15.1K | $ -2.39M | $ -1.98M | $ 110.0K | $ 18.0K |
| 2002 | $ 39.4K | $ -1.59M | $ -1.37M | $ 110.0K | $ -630.0K |
| 2001 | $ 53.0K | $ -1.10M | $ -1.37M | $ 388.0K | $ -1.34M |
| 2000 | $ 89.3K | $ -788.9K | $ -667.7K | $ 18.0K | $ -799.0K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.80 |
| Liabilities / Eq | -1.01 |
| Current Ratio | 0.00 |

## Other views

- [Metrics](https://sponda.capital/en/PFND.md)
- [Charts](https://sponda.capital/en/PFND/charts.md)
- [Compare](https://sponda.capital/en/PFND/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.